Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-12-063597

Options or other derivatives

  • Director acquired 210,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Isabelle Warren John · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-11-16 Grant or award : show line 1 in the form Common Stock Option +210,000 $0.17 2022-11-16 2,100,000 490,000 D
Loading xslF345X03/form454599_20121116054220-.xml…